Immunology and Microbiology
COVID-19
100%
Allergic Asthma
50%
Immunoglobulin E
50%
Ro Antibody
50%
Immune Dysregulation
50%
Chemotaxis
50%
Omalizumab
50%
Pneumonitis
50%
Lupus Erythematosus
50%
Ropeginterferon Alpha2b
50%
B Cell
40%
Systemic Lupus Erythematosus
40%
Interleukin-33
35%
Interleukin 13
31%
Blood Plasma
30%
CD19
30%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Asthma
21%
CXCR4
21%
T-Helper Cell
20%
CD4
20%
Plasmablast
20%
Regulatory T Cell
20%
Monocyte
20%
Stem Cell Transplantation
20%
CD16
20%
Cytokine
20%
T Cell
17%
Blood Level
14%
Myofibroblast
14%
Interleukin-1
10%
Dendritic Cell
10%
Placenta
10%
Adaptive Immune System
10%
Ferritin Blood Level
10%
Memory T Cell
10%
CD14
10%
Immune Response
10%
Mesenchymal Stem Cell
10%
Mortality Rate
10%
Immunocompetent Cell
10%
Immunosuppressive Therapy
10%
Interleukin-6
10%
Innate Immune System
10%
Right Lung
10%
Mycophenolic Acid
10%
Lymphocytopenia
10%
Nephritis
10%
Pulse Rate
10%
C-Reactive Protein
10%
Medicine and Dentistry
Ro Antibody
50%
Pneumonia
50%
Pleural Fibrosis
50%
Mesothelial Cell
50%
COVID-19
50%
Acute Lung Injury
50%
Lupus Erythematosus
50%
Immune Dysregulation
50%
B Cell
40%
Systemic Lupus Erythematosus
40%
Effusion
31%
Histone Deacetylase Inhibitor
25%
Plasmablast
20%
T-Helper Cell
20%
Monocyte
20%
Acute Respiratory Distress Syndrome
20%
Cytokine
20%
Stem Cell Therapy
20%
Gram-Positive Bacteria
18%
Pleura Thickening
12%
Pulmonary Hemorrhage
10%
Nephritic Syndrome
10%
Organizing Pneumonia
10%
Pulmonary Infiltrate
10%
Plasma Exchange
10%
Right Lung
10%
Lung Biopsy
10%
Broad-Spectrum Antibiotic
10%
Hypoxemia
10%
6 Aminonicotinamide
10%
Lymphocytopenia
10%
Intravenous Drug Administration
10%
Immunosuppressive Treatment
10%
Lactate Dehydrogenase
10%
Placenta
10%
Flow Cytometry
10%
Interleukin-6
10%
Memory T Cell
10%
Mortality Rate
10%
Immunocompetent Cell
10%
Interleukin-1
10%
T Cell
10%
Adverse Event
10%
Infection
10%
Pulse Rate
10%
Dendritic Cell
10%
Ferritin
10%
Innate Immunity
10%
Isoprenaline
10%
Interleukin 13
10%
Pharmacology, Toxicology and Pharmaceutical Science
Allergic Asthma
50%
Pleural Fibrosis
50%
Acute Lung Injury
50%
Coronavirinae
50%
Disease
50%
Immune Dysregulation
50%
Immunoglobulin E
50%
Omalizumab
50%
Randomized Controlled Trial
50%
Ropeginterferon Alpha2b
50%
Interleukin 13
31%
Effusion
31%
Histone Deacetylase Inhibitor
25%
SARS Coronavirus
22%
Asthma
21%
Infection
21%
Adult Respiratory Distress Syndrome
20%
Cytokine
20%
Gram Positive Bacterium
18%
Lung Infiltrate
16%
Adverse Event
15%
Airway Remodeling
14%
Pleura Thickening
12%
6 Aminonicotinamide
10%
Ferritin
10%
Immunosuppressive Agent
10%
Lymphocytopenia
10%
C Reactive Protein
10%
Flow Cytometry
10%
Mortality Rate
10%
Lactate Dehydrogenase
10%
Smooth Muscle Actin
7%
Lipoteichoic Acid
6%
Symptom
5%
Clinical Study
5%
Interferon
5%
Proline
5%
Antivirus Agent
5%
